# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-055623
Filing Date
2022-02-28
Accepted
2022-02-28 06:10:54
Documents
9
Period of Report
2022-02-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | d69418d6k.htm | 6-K | 10127
2 | EX-99.1 | d69418dex991.htm | EX-99.1 | 322377
3 | GRAPHIC | g69418g04a55.jpg | GRAPHIC | 16982
4 | GRAPHIC | g69418g05s66.jpg | GRAPHIC | 10818
5 | GRAPHIC | g69418g08s51.jpg | GRAPHIC | 641227
6 | GRAPHIC | g69418g09a22.jpg | GRAPHIC | 528821
7 | GRAPHIC | g69418g35s66.jpg | GRAPHIC | 34851
8 | GRAPHIC | g69418g43b83.jpg | GRAPHIC | 7296
9 | GRAPHIC | g69418g48v28.jpg | GRAPHIC | 1835
| Complete submission text file | 0001193125-22-055623.txt |  | 2038218

Mailing Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141
Business Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141 61 3 9826 0399
Opthea Ltd (Filer) CIK: 0001815620 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-39621 | Film No.: 22683773
SIC: 2836 Biological Products, (No Diagnostic Substances)